Mesa Laboratories (NASDAQ:MLAB - Get Free Report) posted its quarterly earnings results on Tuesday. The medical instruments supplier reported $2.07 EPS for the quarter, topping analysts' consensus estimates of $1.41 by $0.66, Zacks reports. Mesa Laboratories had a positive return on equity of 28.52% and a negative net margin of 107.56%.
Mesa Laboratories Trading Up 4.1 %
Shares of Mesa Laboratories stock traded up $5.86 during midday trading on Friday, reaching $147.59. The company had a trading volume of 47,367 shares, compared to its average volume of 33,223. The stock has a fifty day moving average price of $134.14 and a 200 day moving average price of $125.77. Mesa Laboratories has a fifty-two week low of $83.68 and a fifty-two week high of $152.75. The firm has a market cap of $801.41 million, a PE ratio of -3.24 and a beta of 0.83. The company has a debt-to-equity ratio of 0.65, a current ratio of 0.70 and a quick ratio of 0.51.
Mesa Laboratories Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Monday, March 17th. Stockholders of record on Friday, February 28th will be paid a $0.16 dividend. The ex-dividend date of this dividend is Friday, February 28th. This represents a $0.64 annualized dividend and a dividend yield of 0.43%. Mesa Laboratories's payout ratio is -1.40%.
Analysts Set New Price Targets
Separately, StockNews.com downgraded Mesa Laboratories from a "buy" rating to a "hold" rating in a report on Wednesday, November 13th.
Read Our Latest Report on Mesa Laboratories
Mesa Laboratories Company Profile
(
Get Free Report)
Mesa Laboratories, Inc develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries.
Featured Articles
Before you consider Mesa Laboratories, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Mesa Laboratories wasn't on the list.
While Mesa Laboratories currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
